Welcome to the WCN 2023 Interactive Program

Session Description:In this session, an international panel of experts will discuss global collaborations, scientific discoveries, clinical innovations, and emerging priorities in the field of multiple sclerosis.Learning Objectives:1.To present ongoing advancement in capturing progression in MS – what have we learned?2.To discuss new diagnostic criteria for myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) and current treatment challenges3.To review updates regarding the diagnostic approach to multiple sclerosis: an international perspective4.To highlight emerging visual and serological biomarkers that may improve our ability to diagnose multiple sclerosis, capture ongoing disease activity, gauge response to therapy, and capture patient reported outcomes

Session Description: The prevalence and incidence of epilepsy are highest in later life with around 25% of new cases occurring in elderly people, many of whom will have concomitant neurodegenerative, cerebrovascular, or neoplastic disease. Difficulties accepting the diagnosis are frequently compounded by its unpredictable nature. Elderly epileptic patients face issues that may alter the approach of AED treatments, including drug ineractions, lower adherence to medications etc. Further studies are needed develop evidence to determine the best treatments for the elderly patients with epilepsy. Learning Objectives: 1. To diagnose subtle seizures in elderly patients with epilepsy2.To improve knowledge how to diagnose and manage status epilepticus in the elderly3.To be able to choose patient-tailored antiseizure medications for the elderly persons with epilepsy

Session Description:This session aims to explore the interface between brain and behaviour through the looking glass of epilepsy. The session aims to link bench with bedside for the clinician developing an understanding of neurobiological, clinical and psychosocial factors that underpin epilepsy & behaviour. Developing comprehensive care paradigms is crucial for these complex disorders and will be discussed as an exercise in clinical service development.Learning Objectives:1.Learn about the brain-behaviour interface, epilepsy being the example 2.Understand how different behaviours, anxiety, depression, and psychosis develop neurobiologically and are expressed in epilepsy across the lifespan 3.Understand clinical paradigms of diagnosis and management

Session Description: New virus, new global health condition, new medical patterns, including neurological features. The involvement of the central and peripheral nervous system and muscles have been described among clinical and paraclinical symptoms and conditions. During this session dedicated to Neuro-Covid, an overview is addressed from epidemiology, pathophysiology to presentations and management.Learning Objectives:1.Describe major mechanisms leading to central and peripheral neurological disturbances during ongoing covid infection and post-covid situation.1.2.Describe the main clinical presentations of Neuro-Covid and paramedical findings.2.Manage properly simple or severe cases of patients suffering from neurological conditions during or following a covid infection.

Session Description: Ultrasound based methods-especially Color Codes Duplex Sonography- are today the basic screening tools for extra- und intracranial occlusive disease in symptomatic and asymptomatic patients.The diagnosis and follow-up -after treatment-of Carotid and Vertebral Artery Disease and of Intracranial Stenosis and Occlusion will be described, also in correlation with reference methods like MR- or CT-angiography.TCD Monitoring of vasospasm following Subarachnoid Hemorrhage is an important tool in the management of this life-threathening disease. The method with refence values and case exaples is described.Ultrasound is also essential in the non-invasive diagnosis of Non-Atherosclerotic Vasculopathies like Dissection and Giant Cell Arteriitis. Advanced high-resolution ultrasound methods are applied and case examples presented. Learning Objectives: 1. to be able to detect the fasciculation more accurately, to differentiate myopathies based on structural changes (perimysium, swelling, inclusion bodies, muscle destruction pattern and so on), and to determine the biopsy site correctly .2. to be able to differentiate neuropathies (demyelination neuropathies, metabolic neuropathies, inherited neuropathies, and so on), and to detect the site of lesion in compression neuropathies based on neuro-sonography findings (swelling, atrophy, axonal structural changes, myelin changes and so on). 3. to be able to consider all already known possibilities in differential diagnosis in neuro-muscular disorders based on an excellent review of previously reported results of neuro-muscular sonography. 

Session Description:In this session, an international panel of experts will discuss global collaborations, scientific discoveries, clinical innovations, and emerging priorities in the field of multiple sclerosis.Learning Objectives:1.To present ongoing advancement in capturing progression in MS – what have we learned?2.To discuss new diagnostic criteria for myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) and current treatment challenges3.To review updates regarding the diagnostic approach to multiple sclerosis: an international perspective4.To highlight emerging visual and serological biomarkers that may improve our ability to diagnose multiple sclerosis, capture ongoing disease activity, gauge response to therapy, and capture patient reported outcomes